相关实验视频

Updated: Jun 9, 2025

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

目前针对食道状细胞癌的向治疗的现状

Amane Jubashi¹, Daisuke Kotani¹, Takashi Kojima¹

¹Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

Current problems in cancer

|October 25, 2024

概括

先进的食道状细胞癌 (ESCC) 治疗正在发展. 免疫检查点抑制剂 (ICI) 是有前途的,目前正在研究新的生物标志物和抗体药物联合体 (ADC),以获得更好的结果.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学

背景情况:

食道癌是一个全球性的健康问题,不同的组织学亚型 (腺癌和状细胞癌) 在不同地区普遍存在.
状细胞癌 (SCC) 仍然是全球占主导地位的类型,尽管西方国家的腺癌发病率不断上升.

研究的目的:

审查目前治疗晚期食道状细胞癌 (ESCC) 的现状.
探索ESCC新兴的向疗法和生物标志物,包括免疫检查点抑制剂 (ICI) 和抗体-药物联合体 (ADC).

主要方法:

对先进的ESCC针对性治疗的最新进展的文献综述.
分析已批准和正在研究的治疗方法,包括ICI和ADC.
在ESCC中讨论ICI响应的预测生物标志物.

主要成果:

免疫检查点抑制剂 (ICI) 已经证明了治疗疗效,并获得了高级ESCC的批准.
PD-L1表达是第一线ICI治疗的当前生物标志物,但正在研究新的预测生物标志物.
新型抗体-药物联合体 (ADC) 显示出治疗高级ESCC的潜力.

结论:

向治疗,特别是ICI和ADC,在治疗高级ESCC方面取得了重大进展.
对预测生物标志物的进一步研究对于优化ICI治疗和个性化ESCC患者的治疗策略至关重要.

关键词:

生物标志物生物标志物食道癌是食道癌的一个类型.食管状细胞癌的癌症免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.精确瘤学是一门精确的专业.有针对性的治疗.

更多相关视频

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...